STOCK TITAN

Vivid Seats Inc Financials

SEAT
FY2025 annual
Revenue $450.5M -30.5% YoY
Net Income $806.1M +5903.2% YoY
EPS (Diluted) Not reported for FY2025
Free Cash Flow -$93.8M -288.7% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Vivid Seats Inc (SEAT) reported $450.5M in revenue for fiscal year 2025, down 30.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SEAT FY2025

Cash conversion diverged sharply from reported profit amid a shrinking revenue base and a substantially reduced asset footprint.

In FY2025, reported net income was $806M while operating cash flow was -$91.6M, suggesting earnings included items that did not arrive as operating cash. Free cash flow was negative at -$93.8M, leaving no internally generated cash for reinvestment or balance-sheet repair.

Revenue fell to $450.5M from $647.9M in FY2024, making the cash shortfall inconsistent with a business simply funding expansion. Total assets also dropped to $636.9M from $1.6B, indicating a major balance-sheet reset alongside the smaller revenue base.

The current ratio declined to 0.6x from 0.8x, so current assets no longer covered current liabilities at year-end. With total liabilities of $722.0M and negative equity, FY2025 ended with a financing structure reliant more on obligations than on an equity cushion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 20 / 100
Financial Health Score 20/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Vivid Seats Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Vivid Seats Inc, and counted as zero in the overall score.

Growth
8

Vivid Seats Inc's revenue declined 30.5% year-over-year, from $647.9M to $450.5M. This contraction results in a growth score of 8/100.

Leverage
82
Liquidity
7

Vivid Seats Inc's current ratio of 0.59 is below the typical benchmark, resulting in a score of 7/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
22

Vivid Seats Inc's operations used $91.6M of cash, and capex of $2.2M added to the outflow, for a free cash flow shortfall of $93.8M. This results in a cash flow score of 22/100.

Returns
0

Not available for Vivid Seats Inc, and counted as zero in the overall score.

Piotroski F-Score Partial
3/7

Vivid Seats Inc passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Vivid Seats Inc used $0.11 of operating cash (-$91.6M OCF vs $806.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$450.5M
YoY-30.5%
5Y CAGR+80.9%

Vivid Seats Inc generated $450.5M in revenue in fiscal year 2025. This represents a decrease of 30.5% from the prior year.

Net Income
$806.1M
YoY+5903.2%

Vivid Seats Inc reported $806.1M in net income in fiscal year 2025. This represents an increase of 5903.2% from the prior year.

EBITDA

Not reported for fiscal year 2025.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$93.8M
YoY-288.7%

Vivid Seats Inc recorded an outflow of $93.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 288.7% from the prior year.

Cash & Debt
$102.7M
YoY-57.8%
5Y CAGR-18.5%

Vivid Seats Inc held $102.7M in cash against $16.5M in long-term debt as of fiscal year 2025, with $303.3M of liabilities due within a year.

Dividends Per Share

Not reported for fiscal year 2025.

Shares Outstanding

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not shown for fiscal year 2025: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks
$18.3M
YoY-20.4%

Vivid Seats Inc spent $18.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 20.4% from the prior year.

Capital Expenditures
$2.2M
YoY-48.8%
5Y CAGR+44.7%

Vivid Seats Inc invested $2.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 48.8% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

SEAT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SEAT annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19
Revenue$403.8M$450.5M-30.5%$647.9M+8.5%$597.4M+16.9%$511.1M+31.2%$389.7M+1573.8%$23.3M-94.2%$403.6M
Income TaxN/A$69.4M+724.3%$8.4M+119.9%-$42.2M-2554.0%-$1.6M-623.0%$304KN/AN/A
Net IncomeN/A$806.1M+5903.2%$13.4M-80.7%$69.4M-1.9%$70.8M+1509.1%-$5.0M+99.4%-$774.2M-1337.7%-$53.8M
EPS (Diluted)N/A$1.12-78.3%$5.15N/AN/AN/AN/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Interest Expense.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SEAT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SEAT annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19
Total Assets$636.9M-61.1%$1.6B+5.5%$1.6B+34.6%$1.2B-18.3%$1.4BN/AN/A
Current Assets$178.5M-48.3%$345.2M+40.3%$246.0M-25.8%$331.5M-45.7%$610.2MN/AN/A
Cash & Equivalents$102.7M-57.8%$243.5M+94.0%$125.5M-50.1%$251.5M-48.6%$489.5M+71.6%$285.3M+251.0%$81.3M
Inventory$18.2M-7.3%$19.6M-6.7%$21.0M+64.4%$12.8M+8.6%$11.8MN/AN/A
Accounts Receivable$43.5M-27.8%$60.3M-12.0%$68.6M+6755.5%$1.0M-86.1%$7.2MN/AN/A
Goodwill$283.9M-69.9%$943.1M-0.4%$947.4M+32.4%$715.3M-0.4%$718.2MN/AN/A
Total Liabilities$722.0M-47.5%$1.4B-4.9%$1.4B-5.8%$1.5B-32.4%$2.3BN/AN/A
Current Liabilities$303.3M-28.8%$425.8M-12.7%$487.8M+29.0%$378.0M-24.0%$497.5MN/AN/A
Long-Term Debt$16.5M-12.2%$18.7M+15.5%$16.2M+8.7%$14.9MN/A$870.9MN/A
Total Equity-$85.1M-132.6%$261.1M+148.6%$105.0M+127.4%-$382.7M+55.5%-$860.7M-216.7%-$271.8M-152.4%$518.3M
Retained Earnings-$1.4B-46.2%-$930.2M+1.0%-$939.6M+7.3%-$1.0B+2.7%-$1.0BN/AN/A

SEAT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SEAT annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19
Operating Cash Flow$7.5M-$91.6M-269.9%$53.9M-63.4%$147.3M+924.8%$14.4M-91.8%$175.8M+618.7%-$33.9M-144.3%$76.5M
Capital Expenditures$144K$2.2M-48.8%$4.2M+372.3%$895K-74.8%$3.6M+214.3%$1.1M+232.0%$341K-72.9%$1.3M
Free Cash Flow$7.4M-$93.8M-288.7%$49.7M-66.1%$146.4M+1253.7%$10.8M-93.8%$174.7M+610.2%-$34.2M-145.5%$75.2M
Investing Cash Flow-$15.4M-$20.2M+24.6%-$26.7M+88.1%-$225.6M-1363.8%-$15.4M-65.0%-$9.3M-22.9%-$7.6M+81.1%-$40.2M
Financing Cash Flow-$7.6M-$29.4M-134.1%$86.1M+298.2%-$43.4M+81.6%-$236.5M-721.9%$38.0M-84.5%$245.5M+542.7%-$55.5M
Dividends PaidN/AN/AN/AN/AN/AN/A$120KN/A
Share Buybacks$2.4M$18.3M-20.4%$23.0M+14.4%$20.1M-38.2%$32.5M$0N/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SEAT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SEAT annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19
Net Margin178.9%2.1%-9.6pp11.6%-2.2pp13.9%+15.1pp-1.3%-3325.4%-13.3%
Return on EquityN/A5.1%-61.0pp66.1%N/AN/AN/A-10.4%
Return on Assets126.6%+125.8pp0.8%-3.7pp4.5%-1.7pp6.2%+6.5pp-0.4%N/AN/A
Current Ratio0.59-0.2x0.81+0.3x0.50-0.4x0.88-0.3x1.23N/AN/A
Debt-to-EquityN/A0.07-0.1x0.15N/AN/AN/AN/A
FCF Margin-20.8%-28.5pp7.7%-16.8pp24.5%+22.4pp2.1%-42.7pp44.8%-147.0%18.6%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$85.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.59), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Vivid Seats Inc's annual revenue?

Vivid Seats Inc (SEAT) reported $450.5M in total revenue for fiscal year 2025. This represents a -30.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Vivid Seats Inc's revenue growing?

Vivid Seats Inc (SEAT) revenue declined by 30.5% year-over-year, from $647.9M to $450.5M in fiscal year 2025.

Is Vivid Seats Inc profitable?

Yes, Vivid Seats Inc (SEAT) reported a net income of $806.1M in fiscal year 2025.

As of fiscal year 2025, Vivid Seats Inc (SEAT) had $102.7M in cash and equivalents against $16.5M in long-term debt.

Vivid Seats Inc (SEAT) recorded an outflow of $93.8M in free cash flow during fiscal year 2025. This represents a -288.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Vivid Seats Inc (SEAT) recorded an outflow of $91.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Vivid Seats Inc (SEAT) had $636.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Vivid Seats Inc (SEAT) invested $2.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Vivid Seats Inc (SEAT) spent $18.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Vivid Seats Inc (SEAT) had a current ratio of 0.59 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Vivid Seats Inc (SEAT) had a return on assets of 126.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Vivid Seats Inc (SEAT) had $102.7M in cash against an annual operating cash burn of $91.6M. This gives an estimated cash runway of approximately 13 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Vivid Seats Inc (SEAT) has negative shareholder equity of -$85.1M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Vivid Seats Inc (SEAT) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Vivid Seats Inc (SEAT) used $0.11 of operating cash (-$91.6M OCF vs $806.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Vivid Seats Inc (SEAT) scores 20 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top